16th Apr 2026 A plain language summary looking at nivolumab + chemotherapy for Asian people with advanced/recurrent stomach or gastroesophageal cancer
11th Apr 2023 Plain Language Summary: the CheckMate 649 study compares nivolumab in combination with chemotherapy with chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus
